Error message

  • Deprecated function: Creation of dynamic property MergeQuery::$condition is deprecated in MergeQuery->__construct() (line 1357 of /webdata/web/html/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /webdata/web/html/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /webdata/web/html/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /webdata/web/html/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /webdata/web/html/includes/database/query.inc).

J Nucl Med. 1984 Apr;25(4):506-13

Contrast agents and spectroscopic probes in NMR

Koutcher JA, Burt CT, Lauffer RB, Brady TJ.

Abstract

The demand for higher diagnostic specificity has led to the increased use of "foreign" agents to increase tissue contrast and/or spectroscopic sensitivity in NMR studies. The primary agents used to enhance tissue contrast in NMR imaging are paramagnetic. They cause a decrease in the proton T1 of H2O leading to enhanced signal intensity. This effect depends on the large gyromagnetic ratio of the electron, the number of unpaired electrons, the concentration of paramagnetic ions, the number of coordinated water molecules, and the rate of exchange of water. Spectroscopic enhancement has relied primarily on attempt at isotopic enrichment (usually C-13), which causes a direct increase in signal.

PMID: 6544819
| MGH/HST Martinos Center for Biomedical Imaging

Error

The website encountered an unexpected error. Please try again later.